Merck Begins Tender Offer to Acquire Pandion Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Merck & Co. (NYSE: MRK) | Delayed: 147.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.24 | 52 Week High | $65.46 | |||
| Open | $147.24 | 52 Week Low | $47.97 | |||
| Day High | $147.24 | P/E | 100.16 | |||
| Day Low | $147.24 | EPS | $1.47 | |||
| Volume | 4,001 | |||||
| (NASDAQ: PAND) | Delayed: 60.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.05 | 52 Week High | $ | |||
| Open | $35.76 | 52 Week Low | $ | |||
| Day High | $60.05 | P/E | N/A | |||
| Day Low | $60.05 | EPS | $ | |||
| Volume | 1,360 | |||||
